Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -609 | N/A |
| Depreciation Amortization | 1,409 | N/A |
| Accounts receivable | -262 | N/A |
| Accounts payable and accrued liabilities | 46 | N/A |
| Other Working Capital | -502 | N/A |
| Other Operating Activity | 310 | 0 |
| Operating Cash Flow | $391 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -141 | N/A |
| Sale Of Investment | 513 | N/A |
| Other Investing Activity | -1,313 | 0 |
| Investing Cash Flow | $-941 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 23 | N/A |
| Financing Cash Flow | $23 | $N/A |
| Beginning Cash Position | 1,015 | N/A |
| End Cash Position | 488 | N/A |
| Net Cash Flow | $-526 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | 391 | N/A |
| Capital Expenditure | -141 | N/A |
| Free Cash Flow | 250 | 0 |